Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2a Study of LEV102 Topical Gel in Subjects With Acquired Blepharoptosis

NCT05715346 is registered in ClinicalTrials.gov with Levation Pharma, Ltd. as lead sponsor.

NCT NCT05715346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05715346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2a Study of LEV102 Topical Gel in Subjects With Acquired Blepharoptosis
Lead sponsor
Levation Pharma, Ltd.
Phase
Phase 1/2
Overall status
Completed
Start date
February 23, 2023
Completion date
June 24, 2023
Enrollment
33 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acquired blepharoptosis